IAP

IAP(凋亡抑制剂)蛋白是一种抗凋亡蛋白家族,在逃避凋亡方面发挥着重要作用,因为它们既可以阻断凋亡信号通路,又可以促进存活。该家族的八个成员已在人类中得到描述(BIRC1/NAIP、BIRC2/cIAP1、BIRC3/cIAP2、BIRC4/XIAP、BIRC5/Survivin、BIRC6/Apollon、BIRC7/ML-IAP 和 BIRC8/ILP2)。

IAP 基因编码的蛋白质可直接结合并抑制胱天蛋白酶,因此在决定细胞命运方面发挥着关键作用。反过来,IAP 受凋亡过程中从线粒体释放的内源性蛋白质(胱天蛋白酶的第二种线粒体激活剂和 Omi)的调控。IAP 蛋白家族成员经常在癌症中过度表达,并导致肿瘤细胞存活、化学抗性、疾病进展和预后不良。靶向关键的凋亡调节剂(如 IAP)是一种有吸引力的治疗方法,可用于开发新型癌症疗法。

尽管 IAP 以其调节胱天蛋白酶的能力而闻名,但它也会影响泛素 (Ub) 依赖性通路,这些通路通过激活 NF-κB 来调节先天免疫信号。IAP 家族的几个成员通过调节信号转导通路、细胞因子产生和细胞存活来调节先天和适应性免疫。IAP 对免疫的调节主要通过 cIAP1、cIAP2 和 XIAP 的泛素连接酶功能介导,这些靶标会影响 NF-κB 和 MAPK 信号通路。

IAP (Inhibitor of apoptosis) proteins, a family of anti-apoptotic proteins, have an important role in evasion of apoptosis, as they can both block apoptosis-signaling pathways and promote survival. Eight members of this family have been described in humans (BIRC1/NAIP, BIRC2/cIAP1, BIRC3/cIAP2, BIRC4/XIAP, BIRC5/Survivin, BIRC6/Apollon, BIRC7/ML-IAP and BIRC8/ILP2).

IAP genes encode proteins that directly bind and inhibit caspases, and thus play a critical role in deciding cell fate. The IAPs are in turn regulated by endogenous proteins (second mitochondrial activator of caspases and Omi) that are released from the mitochondria during apoptosis. IAP protein family members are frequently overexpressed in cancer and contribute to tumor cell survival, chemo-resistance, disease progression, and poor prognosis. Targeting critical apoptosis regulators, like IAPs, is an attractive therapeutic way undertaken for the development of new classes of therapies for cancer.

Although best known for their ability to regulate caspases, IAPs also influence ubiquitin (Ub)-dependent pathways that modulate innate immune signaling via activation of NF-κB. Several members of the IAP family regulate innate and adaptive immunity through modulation of signal transduction pathways, cytokine production, and cell survival. The regulation of immunity by the IAPs is primarily mediated through the ubiquitin ligase function of cIAP1, cIAP2, and XIAP, the targets of which impact NF-κB and MAPK signalling pathways.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(7R)-SBP-0636457
(7R)-SBI-0636457; (7R)-SB1-0636457

(7R)-SBP-0636457 是 SBP-0636457 (MS-D43071) 的异构体,可作为实验中的对照化合物,而 SBP-0636457 (SB1-0636457) 是一种 SMAC 模拟物和 IAP 拮抗剂,以 0.27 μM 的 Ki 与 IAP 蛋白的 BIR 结构域结合,可用于实体瘤和血液系统癌症的研究。

1422180-61-7
Control
98.36%
(7R)-SBP-0636457

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础